-+ 0.00%
-+ 0.00%
-+ 0.00%

AbbVie announced that the CERVINO phase III clinical trial obtained positive primary endpoint data.

Zhitongcaijing·09/03/2026 13:17:10
Listen to the news
AbbVie announced that the CERVINO phase III clinical trial obtained positive primary endpoint data.